VJHemOnc is committed to improving our service to you

IDH inhibitors in AML

VJHemOnc is committed to improving our service to you

Courtney DiNardo, MD, MSCE, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of IDH inhibitors in acute myeloid leukemia (AML), which are approved in the relapsed setting for this indication and discusses future approaches using this class of agents. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).


Warning: count(): Parameter must be an array or an object that implements Countable in /home/vjhemonc/public_html/wp-content/themes/vj/single.php on line 248
Share this video  
15th September 2020

Warning: Invalid argument supplied for foreach() in /home/vjhemonc/public_html/wp-content/themes/vj/single.php on line 443

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter